3 Patents
- US124043162025Transgenic T Cell and Chimeric Antigen Receptor T Cell Compositions and Related Methods
Memorial Sloan Kettering Cancer Center
0 cites - US123311292025Chimeric Receptors Targeting ADGRE2 And/or CLEC12A and Uses Thereof
MILLENNIUM PHARMACEUTICALS, Inc.
0 cites - 0 cites